Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Abnormal bleeding tendency (abnormal bleeding), Prolonged bleeding time, and Reduced prothrombin consumption.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Abnormal bleeding tendency (abnormal bleeding), Prolonged bleeding time |
No clinical trials have been registered for Tatsumi factor deficiency.
6 publications have been identified in PubMed for Tatsumi factor deficiency. Research spans Basic Science / Preclinical (50%), Clinical Trial Publication (17%), and Epidemiology / Natural History (17%).
Sancho L (2026). [PMID: 41407862](https://pubmed.ncbi.nlm.nih.gov/41407862/). *Nature*. [Basic Science / Preclinical]
Mabuchi Y (2026). [PMID: 41793835](https://pubmed.ncbi.nlm.nih.gov/41793835/). *Cancer Treat Res Commun*. [Clinical Trial Publication]
Chevallier L (2025). [PMID: 40131457](https://pubmed.ncbi.nlm.nih.gov/40131457/). *Mamm Genome*. [Basic Science / Preclinical]
Mawarikado Y (2025). [PMID: 41257739](https://pubmed.ncbi.nlm.nih.gov/41257739/). *Thromb J*. [Epidemiology / Natural History]
Sato S (2024). [PMID: 38469626](https://pubmed.ncbi.nlm.nih.gov/38469626/). *Am J Physiol Lung Cell Mol Physiol*. [Basic Science / Preclinical]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:19 AM UTC
Online Mendelian Inheritance in Man
Common questions about Tatsumi factor deficiency